Structural and functional characterisation of poly(vinyl alcohol) and heparin hydrogels

Biomaterials

Volumn 29, Issue 35, 2008, Pages 4658-4664

  Nilasaroya, Anastasia ^a   Poole Warren, Laura A ^a   Whitelock, John M ^a   Jo Martens, Penny ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Growth factors; Heparin; Hydrogel; Photopolymerisation; Polyvinyl alcohol

Indexed keywords

GROWTH FACTORS; HEPARIN; HYDROGEL; PHOTOPOLYMERISATION; POLYVINYL ALCOHOL;

BIOACTIVITY; CELL CULTURE; CELL GROWTH; CELL MEMBRANES; CHEMICAL ANALYSIS; COLLOIDS; ERROR ANALYSIS; FORMING; MECHANICAL STABILITY; MOLECULAR WEIGHT; PEPTIDES; POLYSACCHARIDES; SCAFFOLDS; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

FIBROBLAST GROWTH FACTOR 2; HEPARIN; METHACRYLIC ACID; POLYVINYL ALCOHOL;

ANIMAL CELL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HYDROGEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL; TENSILE STRENGTH;

BIOCOMPATIBLE MATERIALS; BIOMECHANICS; CHROMATOGRAPHY, GEL; HEPARIN; HYDROGELS; MATERIALS TESTING; POLYVINYL ALCOHOL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 53149099301     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.08.011     Document Type: Article

References (42)

1. Peppas N.A., Hilt J.Z., Khademhosseini A., and Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 18 11 (2006) 1345-1360
2. Lee K.Y., and Mooney D.J. Hydrogels for tissue engineering. Chem Rev 101 7 (July 11, 2001) 1869-1880
3. Masters K.S.B., Leibovich S.J., Belem P., West J.L., and Poole-Warren L.A. Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice. Wound Repair Regen 10 5 (2002 Sep-Oct) 286-294
4. Bourke S.L., Al-Khalili M., Briggs T., Michniak B.B., Kohn J., and Poole-Warren L.A. A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS PharmSci 5 4 (December 4, 2003) E33
5. Griffith L.G. Polymeric biomaterials. Acta Mater 48 1 (2000) 263-277
6. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23 1 (2005) 47-55
7. Whitelock J.M., and Iozzo R.V. Heparan sulfate: a complex polymer charged with biological activity. Chem Rev 105 7 (July 13, 2005) 2745-2764
8. Wu Z.L., Zhang L., Yabe T., Kuberan B., Beeler D.L., Love A., et al. The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 278 19 (May 2, 2003) 17121-17129
9. Cholakis C.H., and Sefton M.V. In vitro platelet interactions with a heparin-polyvinyl alcohol hydrogel. J Biomed Mater Res 23 4 (1989) 399-415
10. Pieper J.S., Hafmans T., Veerkamp J.H., and van Kuppevelt T.H. Development of tailor-made collagen-glycosaminoglycan matrixes: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 21 6 (2000) 581-593
11. Steffens G.C.M., Yao C., Prevel P., Markowicz M., Schenck P., Noah E.M., et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 10 9/10 (2004) 1502-1509
12. Tae G., Scatena M., Stayton P.S., and Hoffman A.S. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed 17 (2006) 187-197
13. Shu X.Z., Liu Y., Palumbo F.S., Luo Y., and Prestwich G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 25 7-8 (2004) 1339-1348
14. Cai S., Liu Y., Zheng Shu X., and Prestwich G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26 30 (2005) 6054-6067
15. Li Q., Wang D.A., and Elisseeff J.H. Heterogeneous-phase reaction of glycidyl methacrylate and chondroitin sulfate: mechanism of ring-opening-transesterification competition. Macromolecules 36 7 (April 8, 2003) 2556-2562
16. Carmeliet P. Manipulating angiogenesis in medicine. J Intern Med 255 5 (2004) 538-561
17. Wang L.-F., Shen S.-S., and Lu S.-C. Synthesis and characterization of chondroitin sulfate-methacrylate hydrogels. Carbohydr Polym 52 4 (2003/6/1) 389-396
18. Bryant S.J., Davis-Arehart K.A., Luo N., Shoemaker R.K., Arthur J.A., and Anseth K.S. Synthesis and characterization of photopolymerized multifunctional hydrogels: water-soluble poly(vinyl alcohol) and chondroitin sulfate macromers for chondrocyte encapsulation. Macromolecules 37 18 (2004) 6726-6733
19. Mühlebach A., Müller B., Pharisa C., Hofmann M., Seiferling B., and Guerry D. New water-soluble photo crosslinkable polymers based on modified poly(vinyl alcohol). J Polym Sci Part A Polym Chem 35 16 (1997) 3603-3611
20. Martens P., Holland T., and Anseth K.S. Synthesis and characterization of degradable hydrogels formed from acrylate modified poly(vinyl alcohol) macromers. Polymer 43 23 (2002) 6093-6100
21. Anseth K.S., Metters A.T., Bryant S.J., Martens P.J., Elisseeff J.H., and Bowman C.N. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Controlled Release 78 1-3 (January 17, 2002) 199-209
22. Cavalieri F., Miano F., D'Antona P., and Paradossi G. Study of gelling behavior of poly(vinyl alcohol)-methacrylate for potential utilizations in tissue replacement and drug delivery. Biomacromolecules 5 6 (November 8, 2004) 2439-2446
23. Martens P.J., Bryant S.J., and Anseth K.S. Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering. Biomacromolecules 4 2 (2003) 283-292
24. Martens P., and Anseth K.S. Characterization of hydrogels formed from acrylate modified poly(vinyl alcohol) macromers. Polymer 41 21 (2000) 7715-7722
25. Martens P., Blundo J., Nilasaroya A., Odell R.A., Cooper-White J., and Poole-Warren L.A. Effect of poly(vinyl alcohol) macromer chemistry and chain interactions on hydrogel mechanical properties. Chem Mater 19 10 (2007) 2641-2648
26. Nuttelman C.R., Henry S.M., and Anseth K.S. Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials 23 17 (2002) 3617-3626
27. Benoit D.S.W., and Anseth K.S. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 1 4 (2005) 461-470
28. Cushing M.C., Liao J.-T., Jaeggli M.P., and Anseth K.S. Material-based regulation of the myofibroblast phenotype. Biomaterials 28 23 (2007) 3378-3387
29. Benoit D.S.W., Collins S.D., and Anseth K.S. Multifunctional hydrogels that promote osteogenic human mesenchymal stem cell differentiation through stimulation and sequestering of bone morphogenic protein 2. Adv Funct Mater 17 13 (2007) 2085-2093
30. Benoit D.S.W., Durney A.R., and Anseth K.S. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials 28 1 (2007) 66-77
31. Toida T., Huang Y., Washio Y., Maruyama T., Toyoda H., Imanari T., et al. Chemical microdetermination of heparin in plasma. Anal Biochem 251 2 (1997) 219-226
32. Melrose J., and Ghosh P. Determination of the average molecular size of glycosaminoglycans by fast protein liquid chromatography. J Chromatogr A 637 1 (1993) 91-95
33. Barbosa I., Garcia S., Barbier-Chassefiere V., Caruelle J.-P., Martelly I., and Papy-Garcia D. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13 9 (September 1, 2003) 647-653
34. Knox S., Merry C., Stringer S., Melrose J., and Whitelock J. Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J Biol Chem 277 17 (2002/4/26) 14657-14665
35. Padera R., Venkataraman G., Berry D., Godavarti R., and Sasisekharan R. FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J 13 (1999) 1677-1687
36. Zar J.H. Biostatistical analysis. 4th ed. (1999), Prentice Hall, Upper Saddle River, NJ
37. Minitab Inc. Minitab statistical software. Release 15 for Windows. State College, Pennsylvania: 2006.
38. Wu Z.L., Zhang L., Beeler D.L., Kuberan B., and Rosenberg R.D. A new strategy for defining critical functional groups on heparan sulfate. FASEB J 16 6 (April 1, 2002) 539-545
39. Petitou M., Casu B., and Lindahl U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 85 1-2 (2003) 83-89
40. Hirsh J., Anand S.S., Halperin J.L., and Fuster V. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation 103 24 (June 19, 2001) 2994-3018
41. Palacios R., and Steinmetz M. IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41 3 (1985) 727-734
42. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. 1992; 240-7.